In this study, we have sequenced the C-terminal part of the Epstein-Barr virus (EBV)-BNLF-l gene encoding for the latent membrane protein-l from tissues of EBV-positive Danish Hodgkin's disease (HD) and of Danish and Malaysian peripheral T-cell lymphomas (PTLs) and from tonsils of Danish infectious mononucleosis (IM). Our study showed that some of the 7 single-base mutations and the 30-bp deletion p r e viourly detected between codons of amino acid 322 and 366 in the BNLF-1 gene of the nasopharyngeal carcinoma cell line CA0 were present in all Malaysian PTLs and in 60% of the Danish P T b . In HD and the IM cases, the mutations were PSTEIN-BARR VIRUS (EBV) is the causative agent of infectious mononucleosis (M)' and is found in many tumors such as Burkitt's lymphoma,* nasopharyngeal carcinoma Hodgkin's disease (HD): peripheral T-cell lymphomas (PTLs): and lymphomas developing in immunocompromised patient^.^.^ In NPC, HD, and PTLs, the EBV latent membrane protein-l (LMP-1) is the only EBV protein with known oncogenic potential that is often but not always expressed. LMP-1 is expressed by tumor cells in about 65% of NPC8 and in 50% of HD.9 EBV is associated with PTLs more often in Asian (65%)'' than in Western (27%) cases.' However, this difference is mostly attributable to the high number of upper aerodigestive tract PTLs in the Asian material that is almost as strongly associated with EBV (89%) as is NPC. LMP-1 can transform rodent fibroblasts and render them tumorigenic in nude mice." Moreover, it can transform human keratinocytes," inhibit human epithelial cell differentiati~n,'~ and is toxic to cells when expressed at high level^.'^,'^ In transgenic mice LMP-l induces hyperplastic dermatitis and abnormal keratin expression.16 LMP-1 induces DNA synthesisI7 and expression of several lymphocytic activation markers and adhesion m01ecules.l~~'~ Hu and coworkers" recently showed several mutations in the EBV gene encoding for LMP-1 (BNLF-1) in the nude mouse-propagated Chinese NPC CA0 cell line (CAO-BNLF-l) as compared with B95.8 (B95.8-BNLF-1). They also identified one of the mutations, which abolished a Xho I restriction site in exon 1 of the BNLF-1 gene, to be present in 36 of 37 Chinese NPC biopsy specimens but in only 2 of 19 African NPC. Chen and coworkersz1 found similar changes in 50 cases of Taiwanese NPC, with all cases lacking the Xho I restriction site. Furthermore, they show that this restriction site was only absent in 1 of 6 other EBV-positive head and neck tumors and in throat washings from only 6 of 20 samples from a healthy control group.
PSTEIN-BARR VIRUS (EBV) is the causative agent of infectious mononucleosis (M)' and is found in many
tumors such as Burkitt's lymphoma,* nasopharyngeal carcinoma Hodgkin's disease (HD): peripheral T-cell lymphomas (PTLs): and lymphomas developing in immunocompromised patient^.^.^ In NPC, HD, and PTLs, the EBV latent membrane protein-l (LMP-1) is the only EBV protein with known oncogenic potential that is often but not always expressed. LMP-1 is expressed by tumor cells in about 65% of NPC8 and in 50% of HD.9 EBV is associated with PTLs more often in Asian (65%)'' than in Western (27%) cases.' However, this difference is mostly attributable to the high number of upper aerodigestive tract PTLs in the Asian material that is almost as strongly associated with EBV (89%) as is NPC. LMP-1 can transform rodent fibroblasts and render them tumorigenic in nude mice." Moreover, it can transform human keratinocytes," inhibit human epithelial cell differentiati~n,'~ and is toxic to cells when expressed at high level^.'^,'^ In transgenic mice LMP-l induces hyperplastic dermatitis and abnormal keratin expression.16 LMP-1 induces DNA synthesisI7 and expression of several lymphocytic activation markers and adhesion m01ecules.l~~'~ Hu and coworkers" recently showed several mutations in the EBV gene encoding for LMP-1 (BNLF-1) in the nude mouse-propagated Chinese NPC CA0 cell line (CAO-BNLF-l) as compared with B95.8 (B95.8-BNLF-1). They also identified one of the mutations, which abolished a Xho I restriction site in exon 1 of the BNLF-1 gene, to be present in 36 of 37 Chinese NPC biopsy specimens but in only 2 of 19 African NPC. Chen and coworkersz1 found similar changes in 50 cases of Taiwanese NPC, with all cases lacking the Xho I restriction site. Furthermore, they show that this restriction site was only absent in 1 of 6 other EBV-positive head and neck tumors and in throat washings from only 6 of 20 samples from a healthy control group.
These findings suggested the presence of an EBV strain in Asia preferentially associated with NPC. Tumorigenecity studies on SCID and nude mice suggested that the LMP-l protein encoded by the EBV strain of the C A 0 cell line (CAO-LW-1) was more tumorigenic than the LMP-1 protein encoded by the EBV strain B95. 8 indicating that the EBV strain found in NPC is more aggressive than the B95.8 EBV strain. In the carboxy-terminal (Cterminal) part of exon 3 between amino acid 322 and 366, Hu et a1 showed the CAO-BNLF-1 gene to have a 30-bp deletion and 7 single-base mutations.
In cooperation with Hans Knecht's group, we recently reported that the 30-bp deletion and some of the single-base mutations were found in only 5 of 52 cases (10%) of European HD (comprising l of 14 cases from Denmark).*' These findings further substantiated the suggestion that mutations in the BNLF-1 gene primarily occur in Asia, whereas they are only observed in relatively few European HD cases.
In the present study, we have investigated the C-terminal part of the BNLF-1 gene in a large series of EBV-positive Danish HD, Danish and Malaysian PTLs, as well as Danish IM. Our study shows that EBV-positive Malaysian PTLs are as strongly associated with the mutant BNLF-1 gene as Asian NPC and that these mutations are present in more than half of the EBV-positive Danish PTL cases. Our results also indicate that these mutations are more frequent in European HD than previously described and that they occur regularly in conventional European IM. Finally, our results suggest that some of the positions of single-base mutations and the 30-bp deletion in the C-terminal part of the CAO-BNLF-l gene may be hot spots that have mutated independently through the evolution of EBV strains.
MATERIALS AND METHODS
Sixty-two cases of Danish EBV-positive HD (31 cases of nodular sclerosis, 30 cases of mixed cellularity, and 1 case of lymphocytic predominance), 19 cases of Danish EBV-positive PTLs, and tonsils from 9 cases of Danish EBV-positive IM were selected from the frozen tissue bank at the Laboratory of Immunopathology at Aarhus Kommunehospital. Paraffin blocks of 13 cases of Malaysian PTLs were obtained from the Department of Pathology, University of Malaya, Kuala Lumpur, Malaysia. In addition, frozen cell pellets of the EBV cell lines B95.8 and AG 876 were investigated. The diagnosis of HD and its histologic subtypes was based on recognized morphologic criteria. The PTLs were defined immunophenotypically as CD20-/CD3' or (in CD20-/CD3-cases) expression of at least two of the T-cell-associated antigens CD45R0, CD43, or OPD4. The diagnosis of 1M was based on clinical, serologic, morphologic, and immunohistologic evidence. LMP-l expression in frozen tissue samples was shown in Hodgkin and Reed-Sternberg (HRS) cells in HD, in tumor cells in Danish PTLs, and in immunoblasts in IM tonsils by standard three-stage immunohistology using monoclonal antibodies CS.l-4 as previously described.' Malaysian paraffin sections for LMP-1 staining were pretreated in a microwave oven for antigen retrieval and stained as previously de~cribed.'~ EBV early RNA-l (EBER-l) was detected by RNA in situ hybridization as described elsewhere."
Sample preparation. In each case, 5 sections of 10 pm were cut and placed in an Eppendorff tube (Eppendorf, Hamburg, Germany) using disposable Pasteur pipettes (John Poulton Ltd. Barking, Essex, UK). Before and after cutting sections for PCR, morphologic control sections were cut and stained with hematoxylin to show the presence of diagnostic cells. Between cases, the cryostat was cleaned with 70% alcohol, and for each case, a new knife was used. For every 3 cases, two tubes with sections from a pellet consisting of TissueTek (Miles, Elkhart, IN) only was cut as the negative control to the cutting procedure. For paraffin sections, the procedure was the same except for the control sections, which were cut from a paraffin block without tissue. Paraffin sections were deparaffinized with two changes of xylene at 65°C. The pellets were washed with two changes of 100% ethanol and once with 70% ethanol. Two drops of acetone were added to each tube that was then placed in a heating block (37°C) to promote evaporation of the acetone. Sections (both paraffin and frozen) were digested in 250 pL proteinase K (200 pgl mL) for 48 hours at 56°C. The proteinase was inactivated by heating to 98°C for IS minutes. Remains of the tissue were spun down briefly, and the supernatant was used for polymerase chain reaction (PCR).
PCR. The PCR was performed in an automated thermal cycler (Perkin Elmer-Cetus, Norwalk, CT). All primers were synthesized by DNA technology (Aarhus, Denmark). For EBV nuclear antigen-2 (EBNA-2) typing, a single-step PCR procedure was used. Primers flanking a 105-bp deletion in the U2 region encoding for EBNA-2A gave rise to a 378-bp product from EBNA-2A EBV strains and to a 483-bp product from EBNA-2B strains?' In cases where double bands indicated the presence of both EBNA-2A and EBNA-2B, these were further investigated using a two-step EBNA-2-typing PCR procedure amplifying another part of the EBNA-2 gene.27 EBV cell lines B953 and AG876 carrying EBNA-2A and EBNA-2B, respectively, were used as controls. To test for the 30-bp deletion in the C-terminal part of the LMP-1 coding gene BNLF-l, a PCR product of either 316 bp or 286 bp was amplified (from nucleotide position 168,390 to 168,074 according to Hudson et alZx Bidirectional solid-phase dideoxy-sequencing. In the C-terminal part of exon 3 between amino acid 322 and 366, Hu et al showed the CAO-BNLF-I gene to have a 30-bp deletion spanning from position 168,286 to 168,257 and 7 single-base mutations at positions 168,357 (C "* A) and 168,355 (A -T) changing the amino acid 322 from Gln to Asn, at position 168,338 (A + C) changing amino acid 328 from Glu to Ala, at position 168,320 (A + G) shifting the amino acid 334 from Gln to Arg, at position 168,308 (T + C) changing the amino acid 338 from Leu to Ser, at position 168,295 (A + T) not affecting the amino acid sequence, and at 168,225 (T + A) shifting the amino acid 366 from Ser to Thr as compared with B95.8.*" Sequence analysis was performed to show the exact location of the 30-bp deletion and to detect the single base mutations. Sequence analysis was performed in I3 cases of HD, 9 cases of Danish PTLs, 7 cases of Malaysian PTLs, and 3 cases of Danish IM where a deletion had been identified by electrophoresis, and in 10 cases of HD, 4 cases of Danish PTLs, and 6 cases of Danish 1M without electrophoretical evidence of a deletion. In all cases, two parallel PCRs were performed, one for sequencing the sense strand and one for sequencing the antisense strand. The PCR product for sequencing the sense strand was produced with a nonbiotinylated sense primer and a 5' biotinylated antisense primer, and the product for sequencing the antisense strand was produced with a nonbiotinylated antisense primer and a 5' biotinylated sense primer. The amount of PCR product needed for sequencing was estimated by electrophoresis. After the PCR, the amplified fragments were captured from 35 to 50 pL of the reaction mix with 30 pL of streptavidin-conjugated magnetic beads (Dynabeads, Dynal, Norway) according to the manufacturers manual. After several washing steps, the double stranded PCR product was denaturated by incubating with 20 pL of 0.1 molL NaOH for 4 minutes at room temperature. The supernatant containing the PCR product generated by the nonbiotinylated primer was removed. The Dynabeads/single-stranded DNA complex was washed once in 250 mmolL TRIS (pH 8)lO.l Tween 20, once in Tris-EDTA buffer, and once in double distilled water and was resuspended in IO pL of double distilled water. The sequencing reaction was performed according to the manufacturers manual (PRISM Sequenase Terminator Single-Stranded DNA Sequencing Kit; Applied Biosystems, Foster City, CA), using fluorescence labeled dideoxynucleotide terminators. Briefly, 5 p L SX 3-(N-morpholino)-propanesulfonic acid working solution containing Mn'+/isocitrate, 25 pmol nonbiotinylated primer (the same primers as used to amplify the PCR product), and dd water was added on ice to a final volume of 20 pL. The primer was annealed by incubation at 65°C for 2 minutes followed by slow cooling to room temperature over 30 minutes. The T7 terminator mix was added followed by incubation at 37°C for 2 minutes. The T7 DNA polymerase was added, and the sequence reaction was performed at 37°C for 10 minutes. The Dynabeads/DNA complex was washed twice in 250 mmoi/L TriS EBNA-2 typing. In 55 of 60 cases of HD, 16 of 19 cases of Danish PTLs, in 11 of 1 l cases of Malaysian PTLs, and in 9 of 9 cases of IM, EBNA-2A was detected, whereas EBNA-2B was found in 3 of 60 HD and 3 of 19 Danish PTL, cases. In 2 cases of HD, both EBNA-2A and EBNA-2B were amplified using the single-step PCR method, and the result was confirmed with a two-step PCR method amplifying another part of the EBNA-2 gene (Table l) . In EBV cell lines B95.8 and AG876, EBNA-2A and EBNA-2B were detected, respectively.
The 30-bp deletion. In 16 of 56 cases of HD (28%), 11 of 18 (61%) cases of Danish PTLs, 9 of 9 cases (100%) of Malaysian PTLs, and 3 of 9 (33%) cases of IM, the PCR result indicated the presence of a deletion in the BNLF-l gene (Table 1 ). In 1 case of HD, a deletion smaller than 30 bp was detected. In EBV cell line B95.8, no deletion was shown. Cell line AG876 showed evidence of deletion. There were no significant differences between the histologic subtypes of HD. In the Danish PTLs, we compared the presence of the 30-bp deletion with the fraction of EBV-positive tumor cells as shown by EBER-1 in situ hybridization (ISH), but we found no significant difference between cases with and cases without the deletion. In 13 of 16 cases of HD, in 3 of 3 cases of IM, in 9 of 10 cases of Danish PTLs, in 7 of 9 Malaysian PTLs, and in the EBV cell line AG876, sequence analysis showed that the 30-bp deletion consisted of exactly the same base sequence as reported by Hu et al." Examination of the sequence environment surrounding the 30-bp deletion showed two 9-nucleotide repeats coding for 3 Gly residues (Rl, amino acid 343 to 345; and R2, amino acid 353 to 3.55"). The 30-bp deletion contained one of these repeats, but from sequence analysis alone, it was not possible to determine whether the first repeat constituted the first 9 nucleotides of the deletion or whether the second repeat constituted the last 9 nucleotides of the deletion (Fig 1A) . In the HD case with electrophoretical evidence of a deletion smaller than 30-bp, sequence analysis showed a 12-bp deletion located within the nucleotide sequence comprising the 30-bp deletion (Fig 2) .
Single-base mutations. The results are summarized in Table 2 . In only 2 cases of Malaysian PTLs were all 7 singlebase mutations described in the CAO-BNLF-l gene found.22
One of these had an additional single-base mutation (A - For C) affecting amino acid 325. Six of the seven single-base mutations found in the C A 0 cell line were detected in 28 cases (1 1 HD, 9 Danish PTLs, 5 Malaysian PTLs, and 3 IM) containing the 30-bp deletion. In all cases, the mutation (A --t C) affecting amino acid 328 was not present. Twenty of these cases (8 HD, 7 Danish PTLs, 2 Malaysian PTLs, and 3 IM) and the AG876 cell line contained only these 6 singlebase mutations and the 30-bp deletion. One case of Danish SANDVEJ ET AL FTL showed two additional single-base mutations, but these did not affect the amino acid sequence. Ten cases had an additional single-base mutation, 7 of these (2 HD, 2 Danish FTLs, and 3 Malaysian PTLs) at amino acid 335, 1 case of HD at amino acid 328, 1 case of IM at amino acid 330, and 1 case of HD at 333. Two cases of HD did not contain 6 of the 7 single-base mutations. One of these cases had one single-base mutation in the coding triplet for amino acid 322 (C -+ G ) instead of the two found in the CAO-BNLF-I gene. The other case of HD contained only the single-base mutation affecting amino acid 366. In the HD case with a 12 bp deletion, amino acid substitutions at position 334, 338, 342, and 366 were identical to those found in the CAO-BNLF-I gene, but it differed in the coding triplet of amino acid 322 (C --t G ) (data not shown). Furthermore, this case contained a single base mutation in the codon of amino acid 352 (A -+ G ) .
In the 19 cases without the deletion, the shift of amino acid 366 observed in the CAO-BNLF-1 gene was found in all cases. Twelve cases had an amino acid substitution of amino acid 328, but in all cases, it differed from that found in the CAO-BNLF-I gene. The other 7 cases showed an Only positions that are mutated in the CAO-LMP-l sequence or found to mutate in more than one case and changing the amino acid sequence are included. Nucleotides mutated in the CAO-BNLF-1 gene are written in bold and underlined. Nucleotides mutated in our cases and not in C A 0 are only underlined. For personal use only. on August 30, 2017 . by guest www.bloodjournal.org From amino acid change of amino acids 322, 338, 342, and 366, shown to be mutated in the CA0 cell line (2 HD, 1 Danish PTL, and 4 IM). In all 7 cases, the amino acid substitution of amino acid 322 differed from that found in the CA0 cell line. The single-base mutations affecting amino acid 338, 342, and 366, detected in the CAO-BNLF-1 gene were found in all 7 cases, but in 4 cases, amino acid 338 differed from that found in the CA0 cell line because of an additional single base mutation. In the 3 other cases, the amino acid substitution of amino acid 334 found in the CA0 cell line was also detected. Furthermore, single-base mutations were found in the coding triplet for amino acid 335 in 2 cases, amino acid 349 in 2 cases, and amino acid 352 in 7 cases; amino acids 349 and 352 are both located within the sequence which is deleted in the CAO-BNLF-I gene. In addition to this, some of the cases showed additional single-base mutations. Single-base mutations were located in the coding triplet of amino acid 332 (4 cases), 339 (2 cases), 356 (3 cases), 358 (4 cases), 361 (3 cases), 370 (1 case), 376 (4 cases), 377 (1 case), and 388 (1 case). The changes in the coding triplet of amino acids 356, 361, 370, and 377 did not affect the amino acid sequence.
DISCUSSION
Deletion studies have indicated that the amino acid sequence between amino acid 322 and 364 is required for rapid turnover of the LMP-1 protein.I5 The 30-bp deletion is located in this area and may, therefore, affect (prolong) the turnover of the LMP-1 protein and thereby promote a higher level of LMP-1 expression in the cells. In cooperation with Hans Knecht's group, we recently reported the 30-bp deletion to be present in only 10% of European HD casesz3; however, in the present study, we have found this deletion in about 30% of Danish HD cases. This difference is statistically significant (P < .02, x' test). Differences in the techniques applied are not likely to explain this difference, because the same primers have been used to generate the PCR product in the two studies; however, differences in the selection criteria of the material may be part of the explanation. In the former report, few cases from different European countries were investigated, whereas consecutive EBV-positive HD cases from one center were examined in the present study. The fact that the 30-bp deletion and 6 of 7 singlebase mutations are found as frequently in tonsils of acute IM as in HD tissues (about 30%) in Denmark is noteworthy because it shows that the EBV-BNLF-1 mutations are not only found in states of malignancy. This might indicate that the mutations are not of tumor pathogenetic relevance. On the other hand, acute IM is a lymphoproliferative disease that, in affected young individuals, may be the result of a somewhat disturbed response to normal EBV infection. The possibility exists that, even in this (nonneoplastic) response to EBV, the clinical course might be influenced by mutations in the BNLF-1 gene. Recent studies of Asian PTLs have suggested that EBV infection is associated with a more aggressive clinical course.3o." Some of the explanation may come from our demonstration of the 30-bp deletion in the C-terminal part of the BNLF-1 gene in all Malaysian PTLs tested. This indicates that the mutant BNLF-1 gene found in the CA0 cell line is as closely associated with Asian PTLs as with Asian NPC. The higher tumorigenicity of the strains containing these mutations could give infected cells a growth advantage over noninfected tumor cells, leading to the more aggressive course. In Danish PTLs where the 30-bp deletion was shown in about 60% of the cases, the number of EBV-positive tumor cells varied from less than 5% to almost 100%. A growth advantage induced by the mutant strain might be reflected in a correlation between the presence of the mutant strain in the tumor and a high percentage of EBV-positive tumor cells; however, we found no such association in our material, which is relatively small (18 cases).
The mutations in the C-terminal part of the BNLF-1 gene were found significantly more often in Danish PTLs than in Danish HD (P < .02, x' test). This may be either an epiphenomenon or a result of the well-known heterogeneity in the genotypes of HRS cells, thereby suggesting that mutations in the BNLF-1 gene may only become an advantage for the tumor cells with certain genotypes.
It has been suggested that EBV strains containing the mutant BNLF-1 gene could be a substrain of EBNA-2A." However, our results show that this is not the case. All 3 EBNA-2B cases of HD, 2 of 3 EBNA-2B cases of Danish PTLs, and the cell line AG876 containing an EBNA-2B strain had the deletion. It is striking that the deletion was found in 5 of 6 EBNA-2B cases, suggesting that an EBV EBNA-2B strain with the deletion is more tumorigenic than EBNA-2B strains without the deletion.
Because the homology between the EBNA-2A and the EBNA-2B gene is much smaller (53%)32 than the homology between the CAO-BNLF-1 and the B95.8-BNLF-1 gene (95%)," our findings of the 30-bp deletion in both EBVtype A and B may indicate that the 30-bp deletion has been generated independently in the two EBV strains and, therefore, may be the consequence of a deletional hot spot. To further validate this hypothesis, we analyzed the sequence environment of the 30-bp deletion to see if the 30-bp deletion could be generated by a simple mechanism. Our results show that the sequence environment of the 30-bp deletion contains two 9-nucleotide repeats coding for 3 Gly residues (RI, amino acid 343 to 345; and R2, amino acid 353 to 355) and that either the first repeat constituted the first 9 nucleotides of the deletion or the second repeat constituted the last 9 nucleotides of the deletion (Fig 1A) . When examining the possible mechanism generating the 30-bp deletion, we found that a simple explanation, based on the slipped mispairing hypothesis first proposed by Streisinger et al,33.34 could be misalignment of short direct repeats during replication. According to this hypothesis, illegitimate pairing between R2 and the complementary R'1 could occur when the DNA duplex became single stranded at the replication fork ( Fig  IB) . As a result, a single stranded loop is formed containing the R1 repeat and the sequence between R1 and R2. After DNA synthesis, DNA repair enzymes may excise the loop and rejoin the broken ends of the DNA strand. The next round of replication would then generate one deleted and one wild-type duplex. If the 30-bp deletion has been created by this mechanism, it would indicate that the deletion conFor personal use only. on August 30, 2017 . by guest www.bloodjournal.org From tains the first repeat (RI) and, therefore, would consist of the amino acids 343 to 352. These findings support the hypothesis that this area of the BNLF-I gene is a deletional hot spot, and this is further substantiated by our finding of one case with a deletion comprising 12 bp of the sequence of the 30-bp deletion.
Concerning the 7 single-base mutations found in the Cterminal part of the CAO-BNLF-l gene, our results show that the sequenced cases can be divided into two major groups. The majority of cases with the deletion containing at least 6 of the 7 single-base mutations (94%) and cases without the deletion only containing the mutation affecting amino acid 366 (63%). In addition to these two major groups, sequence analysis showed that the single-base mutations reported to affect the coding triplet of amino acid 334, 338, and 342 in the CAO-BNLF-l gene could be detected in 27%, 27%, and 16% of the cases without the deletion, respectively. Furthermore, the 30-bp deletion was shown in two cases without all 6 of the 7 single-base mutations. In one of these cases, the sequence (apart from the 30-bp deletion) was identical to that found in the majority of cases without the deletion (Table 2 Evaluating all the single-base mutations found in the sequenced cases our results show that they are almost all located between nucleotides 168,357 and 168,225, coding for the amino acids 322 to 366." From nucleotide position 168,224 to the stopcodon at position 168,160 only very few single-base mutations were found. In addition to this the majority of single base mutations were clustered to the coding triplet of certain amino acid positions (Table 2) . According to Cooper and K r a~c z a k , ?~ potential hot spots for mutations can be defined as codons characterized either by a single base being affected by at least two nonidentical substitutions or by mutations affecting two or three nucleotides within that codon.37 Using this definition, the following coding triplets in the C-terminal part of the BNLF-I gene could be characterized as hot spots: codon 322 (CANGln, GANGlu, ACA/Thr, and AAT/Asn), codon 328 (GANGlu, CANGln, GCNAla, GGA/Gly), codon 331 (GGNGly, CANGln), codon 335 (GGC/Gly, AGC/Ser, GAC/Asp, TGC/Cys), codon 338 (TTG/Leu, TCG/Ser, TCA/Ser, CCG/ Pro), codon 349 (GAT/Asp, GCT/Ala, ACT/Thr), and codon 352 (CAT/His, AAT/Asn, CGT/Arg) (see Table 2 ). This indicates that 4 of the single-base mutations found in the Cterminal part of the CAO-BNLF-1 gene affect codons that could be hot spots.
Moorthy and Thorley-Lawson" recently showed that the ability of LMP-1 to transform Rat-l cells depends on dephosphorylation on Thr 324. A possible hot spot at the position of amino acid 322 could be of special interest, because it is located only two amino acids from the phosphorylation site at Thr 324 and because the amino acid substitution observed in the CA0 cell line is only found in cases with the deletion. By interfering with phosphorylation at Thr 324, the mutation may cause increased levels of dephosphorylated LMP-1 in the cell. Another interesting potential hot spot is the coding triplet for amino acid 352, because it is located at the 3' end of the 30-bp deletion.
Alternatively, to cause functional changes in the LMP-I protein, the potential hot spots identified in the present study could be the result of immune selection by HLA-restricted cytotoxic T-lymphocytes (CTL). Thus, de Campos-Lima and associates reported the loss of HLA-A1 1 restricted CTL epitopes of EBV in two populations (New Guinea and China) with a high frequency of HLA-A 1 1, suggesting that the virus may adapt to host immunos~rveillance.~~~~" Recent studies on target antigens for the human CTL response to EBV agree that the majority of recognized epitopes are located in the EBNA-3 far nil^.^',^' In one report, CTL epitopes were also identified in the LMP-I pr~tein.~' Interestingly, one of these epitopes was detected in LMP-1 from the B95.8 cell line (EBV subtype A) but not in LMP-I from cell line AG876 (EBV subtype B). In our study, we detected the 30-bp deletion and 6 single-base mutations in the C-terminal part of the BNLF-I gene in the AG876 cell line. If the EBV type A-specific CTL epitope in LMP-l is located in the C-terminal part, virus strains (like the AG876) might be rendered nonimmunogenic as a result of the single-base mutations or the 30-bp deletion.
We conclude that the 30-bp deletion and the single-base mutations found between amino acid 322 and 366 in the Cterminal part of the BNLF-1 gene may not characterize a new EBV strain but more likely represent hot spots, suggesting that the 30-bp deletion and the single-base mutations have occurred independently at several occasions during the evolution of EBV strains. A possible pathogenetic role of the mutations in the C-terminal part of the BNLF-1 gene has yet to be established, but our finding of the 30-bp deletion and 6 of the 7 single-base mutations in all cases of Malaysian PTLs and in the majority of Danish PTLs suggests that these mutations may constitute an advantage to EBV in some EBV-associated diseases.
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